Q/C Technologies, Inc. (QCLS)Technology | Computer Hardware | New York, United States | NasdaqCM
3.43 USD
-0.18
(-4.986%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 3.38 -0.05 (-0.050%) ⇩ (July 13, 2026, 7:14 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:26 a.m. EDT
The immediate outlook is severely clouded by a relentless multi-year price collapse, with the stock down nearly 100% over the last nine years and every single year showing negative returns. This consistent failure to generate shareholder value suggests deep structural issues that outweigh the company's recent strategic pivot to optical AI chips. While the relocation to San Francisco and new initiatives offer a potential narrative for future recovery, the market has not yet rewarded these efforts, evidenced by the stock trading near its five-year low despite the hype. Fundamentally, the picture is dire: the company is burning through cash with significant operating losses, negative free cash flow, and a return on equity that is deeply negative. There is no dividend to provide income, and the balance sheet shows no cushion against continued burn. For investors, this looks like a speculative gamble on a turnaround story rather than a sound investment, given the lack of profitability and the history of eroding value. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.045530 |
| AutoETS | 0.046337 |
| AutoTheta | 0.046343 |
| AutoARIMA | 0.054891 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 0.16 |
| Ljung-Box p | 0.042 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 4.58 |
| Attribute | Value |
|---|---|
| Sector | Technology |
| Market Cap | 26,937,262 |
| Beta | 2.14 |
| Previous Name | MyMD Pharmaceuticals, Inc. |
| Website | https://www.qctechnologies.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.64607847 |
| Address1 | 1,185 Avenue of the Americas |
| Address2 | Suite 249 |
| All Time High | 6,566,400.0 |
| All Time Low | 2.5 |
| Ask | 4.33 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 245,980 |
| Average Daily Volume3 Month | 447,603 |
| Average Volume | 447,603 |
| Average Volume10Days | 245,980 |
| Beta | 2.136 |
| Bid | 2.58 |
| Bid Size | 2 |
| Book Value | 2.62 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.43 |
| Current Ratio | 3.715 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 3.65 |
| Day Low | 3.38 |
| Display Name | Q/C |
| Ebitda Margins | 0.0 |
| Enterprise Value | 17,080,240 |
| Eps Trailing Twelve Months | -8.49 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.92 |
| Fifty Day Average Change | -0.49 |
| Fifty Day Average Change Percent | -0.125 |
| Fifty Two Week Change Percent | -64.60785 |
| Fifty Two Week High | 17.4 |
| Fifty Two Week High Change | -13.969999 |
| Fifty Two Week High Change Percent | -0.80287355 |
| Fifty Two Week Low | 2.5 |
| Fifty Two Week Low Change | 0.93000007 |
| Fifty Two Week Low Change Percent | 0.37200004 |
| Fifty Two Week Range | 2.5 - 17.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,390,487,400,000 |
| Float Shares | 7,776,858 |
| Free Cashflow | -6,543,574 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 3 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07854 |
| Held Percent Institutions | 0.07991 |
| Implied Shares Outstanding | 7,853,429 |
| Industry | Computer Hardware |
| Industry Disp | Computer Hardware |
| Industry Key | computer-hardware |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,756,771,200 |
| Last Split Factor | 1:100 |
| Long Business Summary | Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. In addition, it is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications;. The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York. |
| Long Name | Q/C Technologies, Inc. |
| Market | us_market |
| Market Cap | 26,937,262 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_694917951 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -14,574,655 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 28,350,878 |
| Open | 3.64 |
| Operating Cashflow | -9,711,942 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 856 848 8698 |
| Post Market Change | -0.049999952 |
| Post Market Change Percent | -1.4577246 |
| Post Market Price | 3.38 |
| Post Market Time | 1,783,984,485 |
| Prev Name | MyMD Pharmaceuticals, Inc. |
| Previous Close | 3.61 |
| Price Hint | 4 |
| Price To Book | 1.3091604 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.521 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.18 |
| Regular Market Change Percent | -4.98615 |
| Regular Market Day High | 3.65 |
| Regular Market Day Low | 3.38 |
| Regular Market Day Range | 3.38 - 3.65 |
| Regular Market Open | 3.64 |
| Regular Market Previous Close | 3.61 |
| Regular Market Price | 3.43 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 246,718 |
| Return On Assets | -0.19638 |
| Return On Equity | -0.62582 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Technology |
| Sector Disp | Technology |
| Sector Key | technology |
| Shares Outstanding | 7,853,429 |
| Shares Percent Shares Out | 0.19459999 |
| Shares Short | 1,528,623 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,625,671 |
| Short Name | Q/C Technologies, Inc. |
| Short Percent Of Float | 1.0511 |
| Short Ratio | 5.18 |
| Source Interval | 15 |
| State | NY |
| Symbol | QCLS |
| Total Cash | 12,974,924 |
| Total Cash Per Share | 1.652 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -8.49 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.056 |
| Two Hundred Day Average Change | -0.62600017 |
| Two Hundred Day Average Change Percent | -0.15433928 |
| Type Disp | Equity |
| Volume | 246,718 |
| Website | https://www.qctechnologies.com |
| Zip | 10,036 |